Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M910Revenue $M276Net Margin (%)-9.6Altman Z-Score12.1
Enterprise Value $M783EPS $-0.8Operating Margin %-11.2Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.2Pre-tax Margin (%)-11.5Higher ROA y-yN
Price/Book5.710-y EBITDA Growth Rate %--Quick Ratio4.1Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %--Current Ratio4.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-14.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-18.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M32.3ROIC % (ttm)-69.9Gross Margin Increase y-yN

Gurus Latest Trades with GHDX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GHDXDavid Swensen 2013-03-31 Sold Out -2.8%$26.72 - $29.65
($28.5)
$ 27.53-3%Sold Out0
GHDXDavid Swensen 2012-12-31 Buy 2.8%$26.42 - $36.8
($30.13)
$ 27.53-9%New holding37,861
GHDXDavid Swensen 2011-03-31 Sold Out -0.93%$21.08 - $26.18
($23.29)
$ 27.5318%Sold Out0
GHDXDavid Swensen 2010-12-31 Buy 0.93%$13.18 - $23.52
($17.74)
$ 27.5355%New holding38,243
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GHDX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


GHDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Cole G BradleyCOO 2015-06-09Sell4,000$26.244.92 view
Cole G BradleyCOO 2015-05-12Sell4,000$27.54-0.04 view
Popovits Kimberly JPresident and CEO 2015-04-13Sell3,000$31.28-11.99 view
Cole G BradleyCOO 2015-04-07Sell4,000$30.44-9.56 view
Popovits Kimberly JPresident and CEO 2015-03-12Sell3,000$31.91-13.73 view
Cole G BradleyCOO 2015-03-10Sell4,000$31.84-13.54 view
Popovits Kimberly JPresident and CEO 2015-02-12Sell3,000$29.86-7.8 view
Cole G BradleyCOO 2015-02-10Sell4,000$31.37-12.24 view
LIVINGSTON RANDALL SDirector 2015-02-02Sell1,000$31.93-13.78 view
Popovits Kimberly JPresident and CEO 2015-01-12Sell3,000$33.46-17.72 view

Quarterly/Annual Reports about GHDX:

News about GHDX:

Articles On GuruFocus.com
CEO of InVitae Corporation of Genomic Health Inc. Randal W. Scott Sold 30,000 Shares Jul 13 2012 
Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Mar 16 2011 
Genomic Health Inc. (GHDX) CFO Dean L Schorno sells 1,000 Shares Mar 16 2011 
Genomic Health Inc. (GHDX) Executive Chairman Randal W Scott sells 20,000 Shares Mar 14 2011 
Genomic Health Inc. (GHDX) COO G Bradley Cole sells 2,500 Shares Mar 10 2011 
Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Feb 16 2011 
Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Feb 16 2011 
Genomic Health Inc. (GHDX) CFO Dean L Schorno sells 1,000 Shares Feb 16 2011 
Genomic Health Inc. (GHDX) Executive Chairman Randal W Scott sells 20,000 Shares Feb 14 2011 
Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Jan 19 2011 

More From Other Websites
Genomic's Oncotype DCIS Score Betters Treatment Guidance - Analyst Blog Jun 25 2015
Healthcare-Focused Fund Camber Capital’s Top Picks: Masimo Corporation (MASI), The Medicines... Jun 23 2015
Journal of Surgical Oncology Publishes Study Showing Oncotype DX® DCIS Score™ Result Changes... Jun 23 2015
Journal of Surgical Oncology Publishes Study Showing Oncotype DX® DCIS Score™ Result Changes... Jun 23 2015
GENOMIC HEALTH INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 17 2015
Genomic Health Liquid Biopsy Test Fit for Bladder Cancer - Analyst Blog Jun 17 2015
Genomic Health Presents Positive Proof-of-Concept Data for Bladder Cancer Liquid Biopsy Test Jun 16 2015
Genomic Health Presents Positive Proof-of-Concept Data for Bladder Cancer Liquid Biopsy Test Jun 16 2015
Edited Transcript of GHDX earnings conference call or presentation 5-May-15 8:30pm GMT Jun 12 2015
Genomic Health to Present Proof-of-Concept Bladder Cancer Liquid Biopsy Data at AACR Precision... Jun 11 2015
Genomic Health to Present Proof-of-Concept Bladder Cancer Liquid Biopsy Data at AACR Precision... Jun 11 2015
Oncotype DX® Presentations at ASCO in Breast and Prostate Cancer Reinforce Genomic Health's... Jun 01 2015
Oncotype DX® Presentations at ASCO in Breast and Prostate Cancer Reinforce Genomic Health's... Jun 01 2015
Genomic's Prostate Cancer Test Recommended by Palmetto - Analyst Blog May 27 2015
Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference May 27 2015
Multiple Oncotype DX® Presentations at the American Society of Clinical Oncology Annual Meeting... May 27 2015
Multiple Oncotype DX® Presentations at the American Society of Clinical Oncology Annual Meeting... May 27 2015
Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference May 27 2015
Genomic Health Announces Favorable Draft Local Coverage Determination from Palmetto GBA® on... May 21 2015
Genomic Health Announces Favorable Draft Local Coverage Determination from Palmetto GBA® on... May 21 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK